Company Filing History:
Years Active: 2019
Title: Michael Koetting: Innovator in Therapeutic Protein Delivery
Introduction
Michael Koetting is a prominent inventor based in Austin, TX (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of polymers for the delivery of therapeutic proteins. His innovative work has the potential to enhance the efficacy of protein-based therapies.
Latest Patents
Michael Koetting holds 1 patent for his invention titled "Polymers for delivery of therapeutic proteins." This patent focuses on improved hydrogel copolymers, which include components such as itaconic acid and N-vinylpyrrolidone. These copolymers are designed for oral delivery of therapeutic proteins. The invention also outlines methods for loading therapeutic proteins into the hydrogel, particularly for proteins with a high isoelectric point. The use of a reduced ionic strength loading solution is a key aspect of this invention, as it can lead to compositions that exhibit improved pharmacokinetic attributes, including better loading and release of therapeutic proteins.
Career Highlights
Michael Koetting is affiliated with the University of Texas System, where he continues to advance research in the field of drug delivery systems. His work is characterized by a commitment to improving patient outcomes through innovative solutions in therapeutic delivery.
Collaborations
One of his notable collaborators is Nicholas Peppas, a respected figure in the field of biomedical engineering. Their partnership has contributed to the advancement of research in polymeric drug delivery systems.
Conclusion
Michael Koetting's contributions to the field of therapeutic protein delivery exemplify the impact of innovative research in biomedical engineering. His work not only enhances the understanding of drug delivery systems but also paves the way for future advancements in patient care.